Attached files
file | filename |
---|---|
10-Q - 10-Q - Artemis Therapeutics, Inc. | zk2126393.htm |
EX-31.1 - EXHIBIT 31.1 - Artemis Therapeutics, Inc. | exhibit_31-1.htm |
EXHIBIT 32.1
CERTIFICATION OF CHIEF EXECUTIVE AND FINANCIAL OFFICERS
PURSUANT TO U.S.C. SEC. 1350
The undersigned officer of Artemis Therapeutics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge:
(i)
|
That the Quarterly Report for the fiscal quarter ended September 30, 2020 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
|
(ii)
|
The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date: August 23, 2021
|
/s/ Chanan Morris
|
|
|
|
By: Chanan Morris, Chief Financial Officer
(Principal Executive Officer, Principal Financial and
Accounting Officer)
|
|